Please join us for the 32nd Annual Biomedical Distinguished Lecture Series featuring Dr. Johnathan Whetstine, director of the Cancer Epigenetics Institute at Fox Chase Cancer Center.

Johnathan Whetstine Ph.D. is Professor and Director of the Cancer Epigenetics Institute as well as Program Leader for the Nuclear Dynamics and Cancer Program at Fox Chase Cancer Center. He holds the endowed Jack Schultz Chair in Basic Science. Dr. Whetstein received his Ph.D. in Pharmacology from Wayne State University in Detroit, Michigan. He was awarded a postdoctoral fellowship in Epigenetics/Pathology at Harvard Medical School in Cambridge, MA. He is the recipient of several honors and awards. Most notably, he was a Leukemia and Lymphoma Society Scholar in 2014 and received the Lung Cancer Discovery Award from the American Lung Association in 2014, 2017 & 2019. Dr. Whetstine is a member of American Association for Cancer Research and American Society of Biochemists and Molecular Biologists.

Dr. Whetstine’s laboratory uses state-of-the-art technologies to address the following areas: (1) the identification and characterization of epigenetic mechanisms driving extrachromosomal DNA amplification and chromosomal rearrangement, therapeutic resistance and tumor heterogeneity; (2) the impact of cancer-associated epigenetic factor variants (mutations and germline) on drug responses; and (3) the direct role of chromatin factors in regulating cell division, especially DNA replication. Dr. Whetstine has several publications in high-profile journals including Molecular Cell, Cancer Discovery and Cell.

The biomedical lecture series is FREE and open to the public. If you need to make an accommodation request, please contact kulkoskyj@chc.edu